Researchers develop eDNA method to prevent emergence of pathogens

NewsGuard 100/100 Score

As the SARS-CoV-2 puts a new focus on zoonotic pathogens, a Washington State University researcher has developed a method to use environmental DNA (eDNA) to detect disease in the vast international trade of aquatic animals.

The problem with monitoring the pet trade is one of magnitude. In the United States alone, more than 225 million live animals are imported every year, the majority destined for the aquatic or pet industries. Creating a "clean trade" by detecting infections in these populations requires huge sample sizes, a labor-intensive and costly process.

In a paper published in Scientific Reports on June 24, Associate Professor of Disease Ecology Jesse Brunner outlines two potential ways to test captive animals for pathogen DNA: batching test samples from individuals and sampling eDNA from the water in the animals' tanks. The eDNA method proved to be much more efficient, Brunner said.

"The best way to prevent the emergence of these pathogens, and the diseases that come from them, is to keep them from getting here in the first place," said Brunner.

It's an important goal but a really hard one because of the scale of the problem. With the eDNA method, you are theoretically sampling an entire population at once, so you are more likely to detect whatever is there, and you can do that much more efficiently than with traditional approaches."

Jesse Brunner, Associate Professor of Disease Ecology, School of Biological Sciences, Washington State University

Environmental DNA is already used to look for the presence of invasive species in places like the Great Lakes. Brunner saw that it might also be useful to sample water from the tanks of captive species being transported in the pet trade since infected animals will shed pathogens into their water.

As an example, Brunner used Bsal (Batrachochochytrium salamandrivorans) a chytrid fungus that threatens salamander populations.

Bsal is a cousin of the devastating Bd (Batrachocytrium dendrobatidis) that was responsible for the decline of more than 500 amphibian species around the world, including 90 that likely went extinct.

Now Bsal has jumped into wild salamander populations in Europe from imported pets from Southeastern Asia.

While it has not yet been found in North America, the threat of Bsal prompted the U.S. Fish and Wildlife Service to enact a ban in 2016 on the import of 201 species of salamanders into the United States, which is home to tremendous salamander diversity.

Brunner's paper outlines the statistical formulas needed to conduct surveillance of imported salamanders for Bsal using eDNA.

It shows the volume of samples needed to be taken and tested to produce a good degree of confidence in a negative or positive result. If proven out, the method could reduce the amount of sampling and work required to effectively monitor the pathogen.

This paper provides the framework for the method, and Brunner and colleagues are currently testing it with real samples.

As part of a Bsal Task Force, Brunner and his colleagues are in conversation with the pet industry which is naturally interested in creating a clean trade for salamanders, but finding better solutions to test for pathogens in salamanders also has broader implications.

"The problem that we're having with amphibians is also the same problem that we're having with all sorts of wildlife and with human disease," said Brunner. "I think if we can solve this problem, we'll be in much better shape to solve others."

Source:
Journal reference:

Brunner, J. L. (2020) Pooled samples and eDNA-based detection can facilitate the “clean trade” of aquatic animals. Scientific Reports. doi.org/10.1038/s41598-020-66280-7.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tracking circulating tumor DNA could indicate gastroesophageal cancer treatment response